Venus Remedies Limited (NSE:VENUSREM)

Venus Remedies Revenue

In the fiscal year ending March 31, 2025, Venus Remedies had annual revenue of 6.48B INR with 7.72% growth. Venus Remedies had revenue of 1.95B in the quarter ending March 31, 2025, a decrease of -0.10%.

• Revenue: 6.48B
• Revenue Growth: +7.72%
• P/S Ratio: 0.95
• Revenue / Employee: 5.46M
• Employees: 1,187
• Market Cap: 6.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	6.48B	464.40M	7.72%
Mar 31, 2024	6.01B	459.40M	8.27%
Mar 31, 2023	5.56B	-446.71M	-7.44%
Mar 31, 2022	6.00B	520.57M	9.50%
Mar 31, 2021	5.48B	2.07B	60.90%